e-ISSN: Pending
Failed Experiment ReportOpen accessImmunologic diseases. Allergy

A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge

Jessica J. Harrison; Wilson Nguyen; Mahali S. Morgan; Bing Tang; Gervais Habarugira; Henry de Malmanche; Morgan E. Freney; Naphak Modhiran · 2024 · npj Vaccines

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Abstract In 2022, a genotype IV (GIV) strain of Japanese encephalitis virus (JEV) caused an unprecedented and widespread outbreak of disease in pigs and humans in Australia. As no veterinary vaccines against JEV are approved in Australia and all current approved human and veterinary vaccines are derived from genotype (G) III JEV strains, we used the recently described insect-specific Binjari virus (BinJV) chimeric flavivirus vaccine technology to produce a JEV GIV vaccine candidate. Herein we describe the production of a chimeric virus displaying the structural prM and E proteins of a JEV GIV

Abstract by Jessica J. Harrison; Wilson Nguyen; Mahali S. Morgan; Bing Tang; Gervais Habarugira; Henry de Malmanche; Morgan E. Freney; Naphak Modhiran, npj Vaccines (2024) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1038/s41541-024-00903-2